Categories: All CategoriesCorporateProductsPipelineFinancial Nov 09, 2020Myriad Genetics Delivers 56% Sequential Increase in Quarterly Revenue; Test Volumes Reach 90% of Pre-COVID-19 Level at End of QuarterFinancialNov 04, 2020Myriad Genetics to Announce Quarterly Financial Results on November 9, 2020FinancialAug 13, 2020Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial ResultsFinancialAug 06, 2020Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020CorporateMay 05, 2020Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial ResultsFinancialApr 28, 2020Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020CorporateApr 08, 2020Myriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus PandemicFinancialFeb 06, 2020Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial ResultsFinancialJan 30, 2020Myriad to Announce Fiscal Second-Quarter 2020 Financial Results on February 6, 2020CorporateNov 04, 2019Myriad Genetics Reports Fiscal First-Quarter 2020 Financial ResultsFinancialAug 13, 2019Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial ResultsFinancialAug 06, 2019Myriad to Announce Fiscal Fourth-Quarter 2019 Financial Results on August 13, 2019FinancialMay 07, 2019Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial ResultsFinancialMay 01, 2019Myriad Genetics to Present at Two Upcoming Healthcare ConferencesFinancialApr 23, 2019Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019Financial Next page